Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03948048

Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock

Sponsor: Children's Hospital of Fudan University

View on ClinicalTrials.gov

Summary

Severe sepsis and septic shock remain the leading causes of child mortality worldwide. Sepsis is a complex process that ultimately leads to circulation disorders, organ perfusion abnormalities, capillary leakage, tissue hypoxia, and organ failure. The difficulty of clinical treatment is microcirculation and mitochondrial dysfunction in septic shock. Once shock enters the stage of microcirculation failure, conventional treatment is ineffective. ECMO can effectively support the circulatory system and provide good oxygen delivery, but there are many controversies in clinical treatment. 1) whether ECMO can effectively improve the clinical prognosis of children with septic shock; 2) appropriate timing for ECMO intervention; 3) which key clinical factors affect the effect of ECMO treatment. This study intends to adopt a multi-center, prospective, non-randomized controlled trial design, and the main research hypothesis is whether ECMO treatment can improve the success of discharge survival of children with septic shock.

Official title: Study on the Efficacy and Timing of Extracorporeal Membrane Oxygenation (ECMO) Therapy in Children With Refractory Septic

Key Details

Gender

All

Age Range

29 Days - 18 Years

Study Type

OBSERVATIONAL

Enrollment

60

Start Date

2020-08-01

Completion Date

2026-12-31

Last Updated

2026-03-16

Healthy Volunteers

No

Interventions

DEVICE

ECMO

ECMO is used to intervene septic shock and refractory septic shock

Locations (1)

Children'S Hosptial of Fuan University

Shanghai, China